CSF3 and Decreased total neutrophil count: The G-CSF agents filgrastim and pegfilgrastim were used in 92 (75%) patients with grade ≥3 neutropenia and were most commonly administered as a single injection (median 1 dose; Q1 1, Q3 3 doses) at 300 μg or 6 mg subcutaneously, respectively.